openPR Logo
Press release

Depression Drug Market: Global Depression Drug Forecast Will Reach $16.8 billion by 2020

06-15-2017 03:00 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Market Research Store

Depression Drug Market

Depression Drug Market

Zion Market Research has published a new report titled “Depression Drug (Benzodiazepines, SNRIs, TCAs, TeCAs, Atypical Antipsychotics, Monoamine Oxidase inhibitors and Others) Market: Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 – 2020” According to the report, the global depression drug market was valued at USD 14.51 billion in 2014 and is expected to generate revenue of USD 16.8 billion by end of 2020, growing at a CAGR of 2.50% between 2015 and 2020.

Depression is a medical disorder that mainly involves brain. Individual with depression feel sad, tired, lack energy, and have intricacy enjoying routine activities every day. It is a very common condition that affects about 1 in every 5 individual in the U.S. Many factors can cause depression, including genes, factors such as stress and brain chemistry. According to WHO (world health organization and center for disease control) at present an estimated 350 million people worldwide are affected with depression.

Request For Free Sample Report:

Some of the key reasons driving depression drug market are growing geriatric population, rising efficacy and declining side effects of drugs in numerous classes. Nevertheless, present circumstances specifies that the overall depression drug market would decline owing to patent expiry of main antidepressants, rising number of generic drug variants and weak pipeline of new drugs.

Different types of depression also have dissimilar symptoms. Several types of depression disorders include postpartum depression, major or clinical depressive disorder, dysthymic disorder, psychotic depression and seasonal affective disorder. Different classes of depression drugs are anticonvulsants, serotonin-norepinephrine reuptake inhibitors, beta-blockers, benzodiazepines, tetracyclic antidepressants (TeCAs), selective serotonin reuptake inhibitors (SSRIs) and monoamine oxidase inhibitors (MAOIs) among others. Among all classes, SNRIs emerged as budding segment in 2014 and held more than 32% of the overall market share. However, it is predicted that this segment may exhibit decline in growth in the near future.

Know more before buying this report:

Geographically, North America emerged as major regional market for the global depression drug in 2014. This dominance was mainly because of presence of large population infected with numerous kinds of depression and anxiety disorders. Currently, U.S. is saturated as a variety of antidepressant drugs are available on prescription for the similar symptom. Depression drug market growth heavily relies on introduction of more efficient drugs for latest symptoms. Asia Pacific is predicted to show moderate growth due to presence of emerging economies such as Japan, Australia and China. Growth in this region is attributed to different factors such as positive marketing approval for novel medicines, presence of a large population base in the region and increasing geriatric population.

Browse the full report at:

Major companies operating in this field are H. Lundbeck, Opko Health, Gedeon Richter, Intra-Cellular Therapies, Janssen Pharmaceuticals, Lupin, Luye Pharma, MSI Methylation Sciences, Naurex, Abbott Laboratories, Novartis, Otsuka Pharmaceutical and SK Biopharmaceuticals among others.

This report segments the global depression drug market as follows:

Class Segment Analysis: Atypical Antipsychotics, Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Tetracyclic Antidepressants, Monoamine Oxidase inhibitors, Benzodiazepines, Others

Regional Segment Analysis: North America (US), Europe(Germany, France, UK), Asia Pacific(China, Japan, India), Latin America(Brazil), Middle East and Africa

About Us: Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Joel John
3422 SW 15 Street,Suit #8138
Deerfield Beach,Florida 33442
United States
Toll Free: +1-855-465-4651 (USA-CANADA)
Tel: +1-386-310-3803

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Depression Drug Market: Global Depression Drug Forecast Will Reach $16.8 billion by 2020 here

News-ID: 581194 • Views: 369

More Releases from Market Research Store

Global Low- and No-Calorie Soda Market 2020 RC Cola, Zevia, Carabao, PepsiCo, Dr …
Global Low- and No-Calorie Soda Industry Competitive Analysis - Forecast and Historical Market Analysis by Key Market Segments The research report on the global Low- and No-Calorie Soda market encompasses a wide-scope analysis of various macro economic and micro economic factors affecting the industry performance on a regional and global level. The research report offers a detailed outline of the industry chain components including suppliers, customers, manufacturers, and distributors. Moreover, the
Global Robotics Market 2020 Boeing, Northrop Grumman Corp., Swisslog, Amazon, iR …
Robotics: Regional and Global Market Opportunities - Key Competitors, Industry Segments, and Strategic Analysis, 2020-2025 The market study is primarily based on primary and secondary data collected through systematic research approach. The research approach is defined by expert market analysts in line with business consultants and international research standards. Economic, political, and environmental regulations for Robotics market are examined to draw the conclusion on macroeconomic business environment. The market study also
Global Wood Preservatives Market 2020 Nippon Paint Co. Ltd., Koppers, Ronseal, R …
Wood Preservatives Market Global and outlook (2015 - 2025) The report published on Wood Preservatives is a invaluable foundation of insightful data helpful for the decision-makers to form the business strategies related R&D investment, sales and growth, key trends, technological advancement, emerging market and more. The global Wood Preservatives market report includes key facts and figures data which helps its users to understand current scenario of the global market along
Global Decorative Paints And Coatings Market 2020 Materis, Nippon Paint Co. Ltd. …
Global Decorative Paints And Coatings Market Analysis by Region (North America, Europe, Asia Pacific, and Middle East and Africa), by Application (Residential Sector, Commercial Sector) and, by Type (Water-based Decorative Paints and Coatings, Solvent-based Decorative Paints and Coatings), 2020-2025 Introduction: Global Decorative Paints And Coatings market is anticipated to grow from USD XX Million in 2019 to USD XX Million by 2025, at a compound annual growth rate of XX% from 2019

All 5 Releases

More Releases for Depression

Global Depression Treatment Therapy Market Research and Forecast, 2018-2023
Increasing Cases of Depression Will Accentuate the Growth of Global Depression Treatment Therapy Market According to OMR analysis, the global depression treatment therapy market is estimated to grow with a significant CAGR during the forecast period. The introduction of virtual reality in the treatment of disorders such as post-traumatic stress disorders is driving the market. However, North America and Europe region are currently leading the market. They make up for
Depression Drugs Market: Increase in Cases of Depression to Boost Market Growth
Transparency Market Research (TMR) has published a new report titled, “Depression Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global depression drugs market was valued at US$ 6,500 Mn in 2017 and is anticipated to decline at a CAGR of 2% from 2018 to 2026. The report suggests that rise in incidence of major depression disorders is projected to drive
Depression Therapeutics Market Forecast till 2025
Antidepressants are used to treat a wide range of mental disorders, including depression, anxiety, and major depressive disorder. Certain neurotransmitters in the brain exist in chemical form such as dopamine and serotonin, which are responsible for maintaining emotional balance such as mood and behavior. Antidepressants cover a wide range of drug categories, including selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants
Global Depression Drugs Market Analysis & Forecast with Upcoming Trends 2022
Global Info Reports has published its new and latest market report based on thorough research on the Depression Drugs Market. This detailed, all-inclusive report renders an integrated approach to growth of the market along with an elaborate and accurate analysis of the complete competitive situation of this market on a global level with the key market trends and newest technologies, being a major part in the market’s growth during the
Animal Depression Medication Market – Global Industry Analysis 2024
Animal Depression Medication Market Overview Emotions may be described as subjective, conscious experiences characterized by psychophysiological expressions, mental states, and biological reactions. Several tests such as cognitive bias test and leaned helplessness models have been developed to understand feelings of optimism and pessimism in animals. Cognitive biases have been shown in wide range of species, including rats, dogs, cats, sheep, and chicks. Get Free PDF Research Brochure for more Professional and Technical
Leading website for Depression Help, DepressionTribe, offers Different Categorie …
DepressionTribe, well known online platform for depression help, offers various categories of depression groups to users. This lets people find the depression group of their choice according to their interests and preferences. There are about 400 groups on the website; these have been sorted into 24 different categories to help users browse through them easily. Carlsbad, CA, 20 December 2011: DepressionTribe, a leading web based platform for